HHS Adviser Called For FDA To Be More Aggressive In Cannabis Space

Former health policy researcher turned HHS policy adviser Rebecca Haffajee believes FDA could be more aggressive in the cannabis space, including by taking more action against companies selling unregulated cannabidiol products and extending its investigations to products that contain tetrahydrocannabinol (THC). FDA also could limit the allowable THC content in cannabis products, she wrote in a policy brief before joining HHS. Haffajee made her recommendations in a Health Affairs policy brief published July 1, but Health Affairs notes the...